Click Holdings Limited (NASDAQ:CLIK – Get Free Report) shares traded up 3.6% during mid-day trading on Tuesday . The company traded as high as $1.49 and last traded at $1.43. 128,251 shares changed hands during mid-day trading, an increase of 417% from the average session volume of 24,817 shares. The stock had previously closed at $1.38.
Analyst Upgrades and Downgrades
CLIK has been the subject of several recent analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research note on Wednesday, June 24th. Wall Street Zen raised shares of Click to a “hold” rating in a report on Saturday, June 13th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Check Out Our Latest Research Report on Click
Click Trading Up 0.0%
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Click stock. Renaissance Technologies LLC bought a new stake in shares of Click Holdings Limited (NASDAQ:CLIK – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 14,200 shares of the company’s stock, valued at approximately $25,000. Renaissance Technologies LLC owned about 1.23% of Click as of its most recent filing with the SEC.
About Click
Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.
Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.
Further Reading
- Five stocks we like better than Click
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Click Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Click and related companies with MarketBeat.com's FREE daily email newsletter.
